ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 117 filers reported holding ANAPTYSBIO INC in Q1 2020. The put-call ratio across all filers is 1.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,015,000 | -17.9% | 50,000 | 0.0% | 0.08% | -18.9% |
| Q1 2022 | $1,237,000 | -64.4% | 50,000 | -50.0% | 0.10% | -54.1% |
| Q4 2021 | $3,475,000 | -66.7% | 100,000 | -74.0% | 0.21% | -51.2% |
| Q3 2021 | $10,443,000 | +4.6% | 385,081 | 0.0% | 0.42% | +25.1% |
| Q2 2021 | $9,985,000 | -28.7% | 385,081 | -40.8% | 0.34% | +8.7% |
| Q1 2021 | $14,008,000 | +0.2% | 650,000 | 0.0% | 0.31% | -6.3% |
| Q4 2020 | $13,975,000 | +45.8% | 650,000 | 0.0% | 0.33% | -9.8% |
| Q3 2020 | $9,588,000 | -51.6% | 650,000 | -26.6% | 0.37% | -51.1% |
| Q2 2020 | $19,790,000 | +26.4% | 885,838 | -20.0% | 0.76% | +3.9% |
| Q1 2020 | $15,655,000 | +164.0% | 1,107,900 | +203.5% | 0.73% | +206.8% |
| Q4 2019 | $5,931,000 | -71.3% | 365,000 | -38.3% | 0.24% | -81.2% |
| Q3 2019 | $20,686,000 | -47.6% | 591,200 | -15.5% | 1.26% | -44.5% |
| Q2 2019 | $39,494,000 | -41.2% | 700,000 | -23.9% | 2.27% | -50.1% |
| Q1 2019 | $67,206,000 | -4.7% | 920,000 | -16.8% | 4.54% | -20.7% |
| Q4 2018 | $70,523,000 | -37.7% | 1,105,557 | -2.6% | 5.73% | -22.2% |
| Q3 2018 | $113,239,000 | +29.2% | 1,135,000 | -8.0% | 7.36% | +13.5% |
| Q2 2018 | $87,622,000 | -31.7% | 1,233,422 | 0.0% | 6.48% | -32.2% |
| Q1 2018 | $128,375,000 | -8.1% | 1,233,422 | -11.0% | 9.57% | -34.5% |
| Q4 2017 | $139,647,000 | +299.6% | 1,386,485 | +38.6% | 14.62% | +136.9% |
| Q3 2017 | $34,950,000 | +82.7% | 1,000,000 | +25.1% | 6.17% | +94.6% |
| Q2 2017 | $19,131,000 | -23.0% | 799,469 | -10.7% | 3.17% | -12.1% |
| Q1 2017 | $24,854,000 | – | 895,626 | – | 3.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |